P. Luque-Linero , M.C. Fernández-Moreno , J.A. Pérez de León-Serrano , L. Castilla-Guerra
{"title":"Importancia de la hipertensión en pacientes con primer episodio de ictus isquémico: estudio retrospectivo de 20 años","authors":"P. Luque-Linero , M.C. Fernández-Moreno , J.A. Pérez de León-Serrano , L. Castilla-Guerra","doi":"10.1016/j.hipert.2023.04.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objectives</h3><p>Hypertension (HT) is a key risk factor for stroke. We evaluated whether the importance of hypertension on the risk of ischemic stroke has increased in recent decades.</p></div><div><h3>Methods</h3><p>Retrospective study of patients with ischemic stroke discharged from 3 hospitals in Seville (Spain), during the periods: 1999-2001, 2014-2016 and 2019-2020.</p></div><div><h3>Results</h3><p>1,379 patients were included, 42.6% women, mean age 69.1 (±<!--> <!-->11) years. HT was the most prevalent vascular risk factor in all periods, with a progressive increase in hypertensive patients (65.9% vs 69.6% vs 74%; <em>P</em> <!-->=<!--> <!-->.029). HT was especially frequent in patients<!--> <!-->≥<!--> <!-->80 years (73% vs 81.9% vs 85.2%; <em>P</em> <!-->=<!--> <!-->.029). At discharge, progressively more antihypertensive drugs were used (in 65% vs 85.1 vs 90.2% of patients; <em>P</em> <!-->=<!--> <!-->.0001), with a clear increase in the number of antihypertensive drugs used (mean 0.9<!--> <!-->±<!--> <!-->0.8 vs 1.5<!--> <!-->±<!--> <!-->1 vs 1.8<!--> <!-->±<!--> <!-->0.8 drugs, <em>P</em> <!-->=<!--> <!-->.0001). The use of diuretics (13.7%-39.3%-65.3%; p<!--> <!-->=<!--> <!-->0.0001), ACE inhibitors (35.5%-43.3%-53.4%; <em>P</em> <!-->=<!--> <!-->.0001) and angiotensin receptor blockers (12.2%-24%-32.4%; <em>P</em> <!-->=<!--> <!-->.0001) increased progressively. On the contrary, the use of calcium antagonists decreased (24%-19.9%-13.7%; <em>P</em> <!-->=<!--> <!-->.0001).</p></div><div><h3>Conclusions</h3><p>In the last 2 decades there has been a greater role for HT among patients with their first ischemic cerebrovascular event. Greater and better control of HT is necessary to reduce the enormous burden of cerebrovascular disease.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hipertension y Riesgo Vascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1889183723000247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives
Hypertension (HT) is a key risk factor for stroke. We evaluated whether the importance of hypertension on the risk of ischemic stroke has increased in recent decades.
Methods
Retrospective study of patients with ischemic stroke discharged from 3 hospitals in Seville (Spain), during the periods: 1999-2001, 2014-2016 and 2019-2020.
Results
1,379 patients were included, 42.6% women, mean age 69.1 (± 11) years. HT was the most prevalent vascular risk factor in all periods, with a progressive increase in hypertensive patients (65.9% vs 69.6% vs 74%; P = .029). HT was especially frequent in patients ≥ 80 years (73% vs 81.9% vs 85.2%; P = .029). At discharge, progressively more antihypertensive drugs were used (in 65% vs 85.1 vs 90.2% of patients; P = .0001), with a clear increase in the number of antihypertensive drugs used (mean 0.9 ± 0.8 vs 1.5 ± 1 vs 1.8 ± 0.8 drugs, P = .0001). The use of diuretics (13.7%-39.3%-65.3%; p = 0.0001), ACE inhibitors (35.5%-43.3%-53.4%; P = .0001) and angiotensin receptor blockers (12.2%-24%-32.4%; P = .0001) increased progressively. On the contrary, the use of calcium antagonists decreased (24%-19.9%-13.7%; P = .0001).
Conclusions
In the last 2 decades there has been a greater role for HT among patients with their first ischemic cerebrovascular event. Greater and better control of HT is necessary to reduce the enormous burden of cerebrovascular disease.
背景与目的高血压(HT)是脑卒中的重要危险因素。我们评估了近几十年来高血压对缺血性中风风险的重要性是否有所增加。方法对西班牙塞维利亚3家医院1999-2001年、2014-2016年和2019-2020年出院的缺血性脑卒中患者进行回顾性研究。结果纳入1379名患者,女性42.6%,平均年龄69.1(±11)岁。HT是所有时期最常见的血管风险因素,高血压患者的血管风险逐渐增加(65.9%对69.6%对74%;P=0.029)。HT在≥80岁的患者中尤其常见(73%对81.9%对85.2%;P=0.029,降压药的使用量明显增加(平均0.9±0.8 vs 1.5±1 vs 1.8±0.8,P=0.001)。利尿剂(13.7%-39.3%-65.3%;P=0.001)、血管紧张素转换酶抑制剂(35.5%-43.3%-53.4%;P=0.0001)和血管紧张素受体阻滞剂(12.2%-24%-32.4%;P=.0001)的使用量逐渐增加。相反,钙拮抗剂的使用减少了(24%-19.9%-13.7%;P=0.0001)。结论在过去20年中,HT在首次缺血性脑血管事件患者中发挥了更大的作用。为了减轻脑血管疾病的巨大负担,有必要对HT进行更大更好的控制。
期刊介绍:
La mejor publicación para mantenerse al día en los avances de la lucha contra esta patología. Incluye artículos de Investigación, Originales, Revisiones, Casos clínicos, Aplicación práctica y Resúmenes comentados a la bibliografía internacional. Además, es la Publicación Oficial de la Sociedad española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial.